Bone sarcoma, a rare form of cancer originating in bone tissue, presents diverse subtypes like osteosarcoma, Ewing sarcoma, and chondrosarcoma, each demanding unique treatment strategies. In cancer research, emphasis lies on unraveling genetic mutations and molecular pathways propelling bone sarcoma progression. Modern tools such as genomic sequencing and molecular profiling aid in pinpointing potential therapeutic targets, paving the way for personalized treatment avenues. Ongoing clinical trials explore innovative drugs and immunotherapies, promising enhanced outcomes for patients grappling with bone sarcoma. A collaborative approach among researchers, clinicians, and patients plays a pivotal role in advancing our comprehension of this intricate disease and fostering more efficacious treatment modalities.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States